Literature DB >> 23090954

Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage.

Krzysztof Pyrc1, Aleksandra Milewska, Tomasz Kantyka, Aneta Sroka, Katarzyna Maresz, Joanna Kozieł, Ky-Anh Nguyen, Jan J Enghild, Anders Dahl Knudsen, Jan Potempa.   

Abstract

Porphyromonas gingivalis is a Gram-negative bacterium associated with the development of periodontitis. The evolutionary success of this pathogen results directly from the presence of numerous virulence factors, including peptidylarginine deiminase (PPAD), an enzyme that converts arginine to citrulline in proteins and peptides. Such posttranslational modification is thought to affect the function of many different signaling molecules. Taking into account the importance of tissue remodeling and repair mechanisms for periodontal homeostasis, which are orchestrated by ligands of the epidermal growth factor receptor (EGFR), we investigated the ability of PPAD to distort cross talk between the epithelium and the epidermal growth factor (EGF) signaling pathway. We found that EGF preincubation with purified recombinant PPAD, or a wild-type strain of P. gingivalis, but not with a PPAD-deficient isogenic mutant, efficiently hindered the ability of the growth factor to stimulate epidermal cell proliferation and migration. In addition, PPAD abrogated EGFR-EGF interaction-dependent stimulation of expression of suppressor of cytokine signaling 3 and interferon regulatory factor 1. Biochemical analysis clearly showed that the PPAD-exerted effects on EGF activities were solely due to deimination of the C-terminal arginine. Interestingly, citrullination of two internal Arg residues with human endogenous peptidylarginine deiminases did not alter EFG function, arguing that the C-terminal arginine is essential for EGF biological activity. Cumulatively, these data suggest that the PPAD-activity-abrogating EGF function in gingival pockets may at least partially contribute to tissue damage and delayed healing within P. gingivalis-infected periodontia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090954      PMCID: PMC3536129          DOI: 10.1128/IAI.00830-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  77 in total

Review 1.  Is the prevalence of periodontitis in the USA in decline?

Authors:  Charles M Cobb; Karen B Williams; Mary M Gerkovitch
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

2.  Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression.

Authors:  P Li; D Wang; H Yao; P Doret; G Hao; Q Shen; H Qiu; X Zhang; Y Wang; G Chen; Y Wang
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

Review 3.  Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.

Authors:  Natalia Wegner; Karin Lundberg; Andrew Kinloch; Benjamin Fisher; Vivianne Malmström; Marc Feldmann; Patrick J Venables
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 4.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

Review 5.  Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Authors:  Pamela Mangat; Natalia Wegner; Patrick J Venables; Jan Potempa
Journal:  Arthritis Res Ther       Date:  2010-06-02       Impact factor: 5.156

Review 6.  The oral microbial consortium's interaction with the periodontal innate defense system.

Authors:  Richard P Darveau
Journal:  DNA Cell Biol       Date:  2009-08       Impact factor: 3.311

Review 7.  Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics?

Authors:  George Hajishengallis
Journal:  Microbes Infect       Date:  2009-04-05       Impact factor: 2.700

8.  Expression of peptidylarginine deiminase from Porphyromonas gingivalis in Escherichia coli: enzyme purification and characterization.

Authors:  Sofía B Rodríguez; Barbara L Stitt; David E Ash
Journal:  Arch Biochem Biophys       Date:  2009-06-21       Impact factor: 4.013

9.  Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray.

Authors:  Ana Paula V Colombo; Susan K Boches; Sean L Cotton; J Max Goodson; Ralph Kent; Anne D Haffajee; Sigmund S Socransky; Hatice Hasturk; Thomas E Van Dyke; Floyd Dewhirst; Bruce J Paster
Journal:  J Periodontol       Date:  2009-09       Impact factor: 6.993

10.  The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease.

Authors:  Vincent E Friedewald; Kenneth S Kornman; James D Beck; Robert Genco; Allison Goldfine; Peter Libby; Steven Offenbacher; Paul M Ridker; Thomas E Van Dyke; William C Roberts
Journal:  J Periodontol       Date:  2009-07       Impact factor: 6.993

View more
  24 in total

1.  Citrullinome of Porphyromonas gingivalis Outer Membrane Vesicles: Confident Identification of Citrullinated Peptides.

Authors:  Daniel Nyberg Larsen; Christian Engelbrecht Mikkelsen; Mads Kierkegaard; Grzegorz P Bereta; Zuzanna Nowakowska; Jakub Z Kaczmarek; Jan Potempa; Peter Højrup
Journal:  Mol Cell Proteomics       Date:  2019-11-21       Impact factor: 5.911

2.  Dysregulation of human miRNAs and increased prevalence of HHV miRNAs in obese periodontitis subjects.

Authors:  Afsar R Naqvi; Maria F Brambila; Gloria Martínez; Gabriela Chapa; Salvador Nares
Journal:  J Clin Periodontol       Date:  2019-01       Impact factor: 8.728

Review 3.  The case for periodontitis in the pathogenesis of rheumatoid arthritis.

Authors:  Jan Potempa; Piotr Mydel; Joanna Koziel
Journal:  Nat Rev Rheumatol       Date:  2017-08-24       Impact factor: 20.543

4.  The activity of bacterial peptidylarginine deiminase is important during formation of dual-species biofilm by periodontal pathogen Porphyromonas gingivalis and opportunistic fungus Candida albicans.

Authors:  Justyna Karkowska-Kuleta; Dominika Bartnicka; Marcin Zawrotniak; Gabriela Zielinska; Anna Kieronska; Oliwia Bochenska; Izabela Ciaston; Joanna Koziel; Jan Potempa; Zbigniew Baster; Zenon Rajfur; Maria Rapala-Kozik
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

Review 5.  Periodontitis: from microbial immune subversion to systemic inflammation.

Authors:  George Hajishengallis
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

6.  Enamel matrix proteins exhibit growth factor activity: A review of evidence at the cellular and molecular levels.

Authors:  Marzena Wyganowska-Świątkowska; Paulina Urbaniak; Michał Marek Nohawica; Małgorzata Kotwicka; Jerzy Jankun
Journal:  Exp Ther Med       Date:  2015-04-07       Impact factor: 2.447

7.  Suppression of T-cell chemokines by Porphyromonas gingivalis.

Authors:  Catherine E Jauregui; Qian Wang; Christopher J Wright; Hiroki Takeuchi; Silvia M Uriarte; Richard J Lamont
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

Review 8.  Periodontal disease and rheumatoid arthritis: the evidence accumulates for complex pathobiologic interactions.

Authors:  Clifton O Bingham; Malini Moni
Journal:  Curr Opin Rheumatol       Date:  2013-05       Impact factor: 5.006

9.  Peptidylarginine deiminase from Porphyromonas gingivalis contributes to infection of gingival fibroblasts and induction of prostaglandin E2 -signaling pathway.

Authors:  K Gawron; G Bereta; Z Nowakowska; K Lazarz-Bartyzel; M Lazarz; B Szmigielski; D Mizgalska; A Buda; J Koziel; Z Oruba; M Chomyszyn-Gajewska; J Potempa
Journal:  Mol Oral Microbiol       Date:  2014-10-21       Impact factor: 3.563

10.  Citrullination in the periodontium--a possible link between periodontitis and rheumatoid arthritis.

Authors:  Oliver Laugisch; Alicia Wong; Aneta Sroka; Tomasz Kantyka; Joanna Koziel; Klaus Neuhaus; Anton Sculean; Patrick J Venables; Jan Potempa; Burkhard Möller; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2015-08-13       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.